COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,609 Articles (22,913 medRxiv, 8,696 bioRxiv)

Most recent first Previous |  Page 1885: Articles 18841-18850  | Next

Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia
Alharbi, N. K., Alghnam, S., Algaissi, A., Albalawi, H., Alenazi, M. W., Albargawi, A. M., Alharbi, A. G., Alhazmi, A., Al Qarni, A., Alfarhan, A., Zowawi, H. M., Alhatmi, H., Alghamdi, J., Alroqi, F., Arabi, Y. M., Hashem, A. M., Bosaeed, M., Aldibasi, O.
10.1101/2021.01.28.21250598 — Posted: 2021-01-31 Discussion: Onsite
Point-of-Care CRISPR-Cas-Assisted SARS-CoV-2 Detection in an Automated and Mobile Droplet Magnetofluidic Device
Chen, F.-E., Lee, P.-W., Park, J. S., Trick, A. Y., Chen, L., Shah, K., Hsieh, K., Wang, T.-H.
10.1101/2021.01.27.21250564 — Posted: 2021-01-31
Mapping a Pandemic: SARS-CoV-2 Seropositivity in the United States
Kalish, H., Klumpp-Thomas, C., Hunsberger, S., Baus, H. A., Fay, M. P., Siripong, N., Wang, J., Hicks, J., Mehalko, J., Travers, J., Drew, M., Pauly, K., Spathies, J., Ngo, T., Adusei, K. M., Karkanitsa, M., Croker, J. A., Li, Y., Graubard, B. I., Czajkowski, L., Belliveau, O., Chairez, C., Snead, K., Frank, P., Shunmugavel, A., Han, A., Giurgea, L. T., Rosas, L. A., Bean, R., Athota, R., Cervantes-Medina, A., Gouzoulis, M., Heffelfinger, B., Valenti, S., Caldararo, R., Kolberg, M. M., Kelly, A., Simon, R., Shafiq, S., Wall, V., Reed, S., Ford, E. W., Lokwani, R., Denson, J.-P., Messing, S., Michael, S. G., Gillette, W., Kimberly, R. P., Reis, S. E., Hall, M. D., Esposito, D., Memoli, M. J., Sadtler, K.
10.1101/2021.01.27.21250570 — Posted: 2021-01-31
REACT-1 round 8 final report: high average prevalence with regional heterogeneity of trends in SARS-CoV-2 infection in the community in England during January 2021
Riley, S., Eales, O., Walters, C. E., Wang, H., Ainslie, K. E. C., Atchinson, C., Fronterre, C., Diggle, P. J., Ashby, D., Donnelly, C. A., Cooke, G., Barclay, W., Ward, H., Darzi, A., Elliott, P.
10.1101/2021.01.28.21250606 — Posted: 2021-01-31
SARS-CoV-2 Seroepidemiology in Children and Adolescents
Levorson, R. E., Christian, E., Hunter, B., Sayal, J., Sun, J., Bruce, S. A., Garofalo, S., Southerland, M., Ho, S., Levy, S., Defillipi, C., Peake, L., Place, F. C., Hourigan, S. K.
10.1101/2021.01.28.21250466 — Posted: 2021-01-31
Impact of age, gender, ethnicity and prior disease status on immunogenicity following administration of a single dose of the BNT162b2 mRNA Covid-19 Vaccine: real-world evidence from Israeli healthcare workers, December-January 2020
Abu Jabal, K., Ben-Amram, H., Beiruti, K., Batheesh, Y., Sussan, C., Zarka, S., Edelstein, M.
10.1101/2021.01.27.21250567 — Posted: 2021-01-31
Mitigation policies and vaccination in the COVID-19 pandemic: a modelling study
Valiati, N. C. M., Villela, D. A. M.
10.1101/2021.01.27.21250651 — Posted: 2021-01-31
Forecasting virus outbreaks with social media data via neural ordinary differential equations
Nunez, M., Barreiro, N., Barrio, R., Rackauckas, C.
10.1101/2021.01.27.21250642 — Posted: 2021-01-31
Neighbourhood-level risk factors of COVID-19 incidence and mortality
van Ingen, T., Brown, K. A., Buchan, S. A., Akingbola, S., Daneman, N., Smith, B. T.
10.1101/2021.01.27.21250618 — Posted: 2021-01-31
Modeling the asymptomatic prevalence of SARS-CoV-2 epidemic in Italy and the ISTAT survey
Traini, M. C., Caponi, C., Ferrari, R., De Socio, G. V.
10.1101/2021.01.27.21250597 — Posted: 2021-01-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).